A, P., L, F., P, G., & J, W. (2015). Activation of wild-type p53 by MDM2 inhibitors: A new strategy for lymphoma treatment. Dove Medical Press.
Cita Chicago Style (17a ed.)A, Pujals, Favre L, Gaulard P, y Wiels J. Activation of Wild-type P53 by MDM2 Inhibitors: A New Strategy for Lymphoma Treatment. Dove Medical Press, 2015.
Cita MLA (8a ed.)A, Pujals, et al. Activation of Wild-type P53 by MDM2 Inhibitors: A New Strategy for Lymphoma Treatment. Dove Medical Press, 2015.
Precaución: Estas citas no son 100% exactas.